Literature DB >> 28573469

Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City.

Mary M Ford1, Elena Ivanina2, Payal Desai3, Linda Highfield4, Baozhen Qiao5, Maria J Schymura5, Fabienne Laraque3.   

Abstract

PURPOSE: Liver cancer (hepatocellular carcinoma (HCC)) incidence and mortality rates are increasing in the United States. New York City (NYC) has a high burden of liver cancer risk factors, including hepatitis C (HCV) and hepatitis B (HBV) infection, which disproportionately affect persons of low socioeconomic position. Identifying neighborhoods with HCC disparities is essential to effectively define targeted cancer control strategies.
METHODS: New York State Cancer Registry data from 1 January 2001 through 31 December 2012 were matched with NYC HCV and HBV surveillance data. HCC data were aggregated to NYC Zip Code Tabulation Areas (ZCTAs). Moran's I cluster analysis, Poisson regression, and geographically weighted Poisson regression were used to identify hotspots in HCC incidence and to examine the spatial associations with viral hepatitis rates, poverty, and uninsured status.
RESULTS: Among NYC residents, 8,827 HCC cases were diagnosed during 2001-2012. Significant clustering was detected in the HCC rates (Moran's I = 0.25) with the strongest clustering found in HCC patients with comorbid HCV infection (Moran's I = 0.47). Poverty and uninsured status were associated (p < 0.05) with increased rates of HCC patients with HBV or HCV infection. Neighborhoods with high rates of HCC without viral hepatitis infection had lower rates of poverty and uninsured status.
CONCLUSIONS: The geographic variation in HCC highlights the need for neighborhood-targeted interventions to address risk factors and barriers to care. The clusters of HCC by viral hepatitis status may serve as a basis for healthcare policymakers and practitioners to prioritize neighborhoods for cancer screening and control efforts.

Entities:  

Keywords:  Geographically weighted regression; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Liver cancer; Moran’s I

Mesh:

Year:  2017        PMID: 28573469     DOI: 10.1007/s10552-017-0897-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  6 in total

1.  Racial disparities of liver cancer mortality in Wisconsin.

Authors:  Amin Bemanian; Laura D Cassidy; Raphael Fraser; Purushottam W Laud; Kia Saeian; Kirsten M M Beyer
Journal:  Cancer Causes Control       Date:  2019-09-17       Impact factor: 2.506

2.  Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update.

Authors:  Meera Sangaramoorthy; Juan Yang; Alice Guan; Mindy C DeRouen; Michele M Tana; Ma Somsouk; Caroline A Thompson; Joseph Gibbons; Chanda Ho; Janet N Chu; Iona Cheng; Scarlett Lin Gomez; Salma Shariff-Marco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-30       Impact factor: 4.090

3.  Ecological Study of Variability in the Relationship between Liver Cancer Mortality and Racial Residential Segregation.

Authors:  Amin Bemanian; Laura D Cassidy; Raphael Fraser; Purushottam W Laud; Kia Saeian; Kirsten M M Beyer
Journal:  Int J Environ Res Public Health       Date:  2021-09-15       Impact factor: 4.614

4.  Association between socioeconomic status and survival in patients with hepatocellular carcinoma.

Authors:  Yongshun Zheng; Xun Zhang; Jinsen Lu; Shuchen Liu; Yeben Qian
Journal:  Cancer Med       Date:  2021-08-20       Impact factor: 4.452

5.  Spatial epidemiologic analysis of the liver cancer and gallbladder cancer incidence and its determinants in South Korea.

Authors:  Jieun Jang; Dae-Sung Yoo; Byung Chul Chun
Journal:  BMC Public Health       Date:  2021-11-14       Impact factor: 3.295

Review 6.  Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma.

Authors:  Ramesh P Thylur; Sanjit K Roy; Anju Shrivastava; Thomas A LaVeist; Sharmila Shankar; Rakesh K Srivastava
Journal:  JGH Open       Date:  2020-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.